Coronavirus: UK signs deal for 60m doses of potential vaccine



Category: Coronavirus outbreak, Pharmaceuticals industry, Vaccines and immunisation, Medical research, GlaxoSmithKline, Alok Sharma, Politics, Business, Infectious diseases, UK news, Microbiology, Science, Society, Health

Summary:

GlaxoSmithKline and Sanofi Pasteur could supply vaccine by early next year if it is successful

The UK has secured a deal for 60m doses of a fifth potential Covid-19 vaccine, positioning itself as one of the leaders in the global race to ensure vaccine supplies with a total of 250m doses secured so far.

In the worldwide scramble, which has been criticised by campaigners who warn vaccine nationalism will cause billions of people in poorer countries to lose out, the UK, the US and EU are in effect securing their own supplies. Wealthy countries are able to take a gamble, signing deals for vaccines that may not work.

Related: Coronavirus vaccine tracker: how close are we to a vaccine?

Continue reading…

Source: Microbiology | The Guardian

Read More

Be the first to comment

Leave a Reply

Your email address will not be published.


*